<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(2)</volume><submitter>Chang WI</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Noninvasive cardiac radioablation is reported to be effective and safe for the treatment of ventricular tachycardia (VT).&lt;h4>Objective&lt;/h4>This study aimed to analyze the acute and long-term effects of VT radioablation.&lt;h4>Methods&lt;/h4>Patients with intractable VT or premature ventricular contraction (PVC)-induced cardiomyopathy were included in this study and treated using a single-fraction 25-Gy dose of cardiac radioablation. To quantitatively analyze the acute response after treatment, continuous electrocardiography monitoring was performed from 24 hours before to 48 hours after irradiation and at the 1-month follow-up. Long-term clinical safety and efficacy were assessed 1-year follow-up.&lt;h4>Results&lt;/h4>From 2019 to 2020, 6 patients were treated with radioablation for</pubmed_abstract><journal>Heart rhythm O2</journal><pagination>119-126</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9975004</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Short-term and long-term effects of noninvasive cardiac radioablation for ventricular tachycardia: A single-center case series.</pubmed_title><pmcid>PMC9975004</pmcid><pubmed_authors>Cuculich PS</pubmed_authors><pubmed_authors>Chang JH</pubmed_authors><pubmed_authors>Choi CH</pubmed_authors><pubmed_authors>Kim HJ</pubmed_authors><pubmed_authors>Chang WI</pubmed_authors><pubmed_authors>Oh S</pubmed_authors><pubmed_authors>Cha MJ</pubmed_authors><pubmed_authors>Robinson CG</pubmed_authors><pubmed_authors>Jo HH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Short-term and long-term effects of noninvasive cardiac radioablation for ventricular tachycardia: A single-center case series.</name><description>&lt;h4>Background&lt;/h4>Noninvasive cardiac radioablation is reported to be effective and safe for the treatment of ventricular tachycardia (VT).&lt;h4>Objective&lt;/h4>This study aimed to analyze the acute and long-term effects of VT radioablation.&lt;h4>Methods&lt;/h4>Patients with intractable VT or premature ventricular contraction (PVC)-induced cardiomyopathy were included in this study and treated using a single-fraction 25-Gy dose of cardiac radioablation. To quantitatively analyze the acute response after treatment, continuous electrocardiography monitoring was performed from 24 hours before to 48 hours after irradiation and at the 1-month follow-up. Long-term clinical safety and efficacy were assessed 1-year follow-up.&lt;h4>Results&lt;/h4>From 2019 to 2020, 6 patients were treated with radioablation for</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-19T16:25:57.141Z</modification><creation>2025-04-19T16:25:57.141Z</creation></dates><accession>S-EPMC9975004</accession><cross_references><pubmed>36873313</pubmed><doi>10.1016/j.hroo.2022.11.006</doi></cross_references></HashMap>